Eva Villamón
Impact in
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
- Immunology top 10%
- Immune Response and Inflammation
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
-
- Cancer therapeutics and mechanisms 4
- Renal and related cancers 3
- Neurology 10
- Neuroblastoma Research and Treatments 10
- Co-authors
- M. Luisa Gil (11 shared papers)Daniel Gozalbo (11 shared papers)Patricia Roig (6 shared papers)José‐Enrique O’Connor (7 shared papers)D Fradelizi (3 shared papers)Celia Murciano (4 shared papers)Rosa Noguera (11 shared papers)Samuel Navarro (9 shared papers)
In The Last Decade
Eva Villamón
30 papers receiving 711 citations
Peers
Comparison fields: 5 of 87
- Infectious Diseases 253
- Immunology 220
- Neurology 144
- Microbiology 56
- Epidemiology 232
Countries citing papers authored by Eva Villamón
This map shows the geographic impact of Eva Villamón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Villamón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Villamón more than expected).
Fields of papers citing papers by Eva Villamón
This network shows the impact of papers produced by Eva Villamón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Villamón. The network helps show where Eva Villamón may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Villamón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 165 | |
| 2 | 2004 | 58 | |
| 3 | Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida -induced production of cytokines. | 2005 | 57 |
| 4 | 2004 | 39 | |
| 5 | 2006 | 38 | |
| 6 | 2013 | 33 | |
| 7 | 2010 | 30 | |
| 8 | 2006 | 30 | |
| 9 | 2006 | 29 | |
| 10 | 2006 | 27 | |
| 11 | 2014 | 23 | |
| 12 | 2015 | 21 | |
| 13 | 2018 | 20 | |
| 14 | 2004 | 20 | |
| 15 | 2008 | 17 | |
| 16 | 2013 | 16 | |
| 17 | 2015 | 15 | |
| 18 | 2019 | 13 | |
| 19 | 2003 | 12 | |
| 20 | 2020 | 11 |
About Eva Villamón
Eva Villamón is a scholar working on Molecular Biology, Neurology, Infectious Diseases, Epidemiology and Immunology, having authored 32 papers that have together received 722 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (10 papers), Antifungal resistance and susceptibility (8 papers), Acute Myeloid Leukemia Research (6 papers), Immune Response and Inflammation (5 papers), Cancer therapeutics and mechanisms (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Renal and related cancers (3 papers) and Fungal Infections and Studies (3 papers). The work is most often cited by research in Infectious Diseases (253 citations), Immunology (220 citations), Neurology (144 citations), Microbiology (56 citations) and Epidemiology (232 citations). Eva Villamón has collaborated with scholars based in Spain, Sweden and France. Frequent co-authors include M. Luisa Gil, Daniel Gozalbo, Patricia Roig, José‐Enrique O’Connor, D Fradelizi, Celia Murciano, Rosa Noguera, Samuel Navarro, Irene Tadeo and Ana P. Berbegall. Their work appears in journals such as Microbes and Infection, PLoS ONE, Clinical & Translational Oncology, Scientific Reports and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.